Owners, management and financials
CVR: 43082671
DKK 2,705,608
Gross profit
Net result: DKK 94,702
Porton Pharmaceutical Chemicals GmbH (100%)
CVR · view owners
Pavlos Kouroupis
CVR · view management
Active
Founded 18 February 2022
CVR · view overview
1 employee
CVR · 2026
Name registered: Porton Pharmasolutions Denmark ApS
CVR · 18/02/2022
View the full event history
Porton Pharmasolutions Denmark ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2022. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Pavlos Kouroupis. The company is owned by Porton Pharmaceutical Chemicals GmbH. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 2,705,608 and a net result of DKK 94,702 compared with DKK -1,682,051 the year before. Equity in the 2025 report amounted to DKK -3,983,464.
Source: annual report 2025, Danish Business Authority
The financial health of Porton Pharmasolutions Denmark ApS appears to be concerning, with a trend of declining gross profits and increasing losses since its inception. In 2025, the company reported a gross profit of 2,705,608 DKK and a profit of 94,702 DKK, which marks a positive shift after consecutive losses in previous years. However, equity remains negative at -3,983,464 DKK, indicating significant financial strain and potential challenges in sustaining operations. The company's position within the pharmaceutical wholesale industry is still emerging, and its ability to achieve consistent profitability and improve equity will be crucial for future growth.
AI-generated summary · Generated 15/08/2026
Selskabets formål er at markedsføre og sælge, samt anden dermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 2.7 mio. | 95 t. | 1.2 mio. | -4 mio. | 1 | |
| 202401/01/2024 – 31/12/2024 | 3.8 mio. | -1.7 mio. | 3.5 mio. | -4.1 mio. | 1 | |
| 202301/01/2023 – 31/12/2023 | -282 t. | -3.3 mio. | 5.9 mio. | -2.4 mio. | 1 | |
| 202218/02/2022 – 31/12/2022 | -959 t. | -3.1 mio. | 2.1 mio. | 932 t. | 1 |
Compared to 404 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of Porton Pharmasolutions Denmark ApS is 43082671.
Porton Pharmasolutions Denmark ApS is owned by Porton Pharmaceutical Chemicals GmbH.
The management of Porton Pharmasolutions Denmark ApS consists of Pavlos Kouroupis.
In 2025, Porton Pharmasolutions Denmark ApS reported a gross profit of DKK 2,705,608.
Porton Pharmasolutions Denmark ApS had 1 employee in 2026 according to the Danish CVR register.
Porton Pharmasolutions Denmark ApS was founded on 18 February 2022.
Claim this page to add your logo and social links. Free to get started.
Porton Pharmasolutions Denmark ApS has published its annual report for 2025. Gross profit came to DKK 2,705,608, and the net result was DKK 94,702.
Address changed to Østerbrogade 226 st. 1, 2100 København Ø (April 30, 2026).
Contact info changed: new phone: 31431979, new email: [email protected], new website: www.portonpharma.com (April 30, 2026).
Porton Pharmasolutions Denmark ApS has published its annual report for 2024. Gross profit came to DKK 3,796,289, and the net result was DKK -1,682,051.
Porton Pharmasolutions Denmark ApS has published its annual report for 2023. Gross profit came to DKK -282,057, and the net result was DKK -3,327,784.
Porton Pharmasolutions Denmark ApS has published its interim report for the period February 18, 2022 to December 31, 2022.
As of February 18, 2022, Pavlos Kouroupis is registered as director of Porton Pharmasolutions Denmark ApS.
As of February 18, 2022, is registered as an owner of Porton Pharmasolutions Denmark ApS with an ownership share of 100%.
Porton Pharmasolutions Denmark ApS was founded on February 18, 2022.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Companies in the same industry and area
CVR 46788176
CVR 19064301
CVR 37726508
CVR 45929698
CVR 25361695
